Cost-effectiveness of 3-Hydroxy-3-Methylglutaryl–Coenzyme A Reductase Inhibitors in the Secondary Prevention of Cardiovascular Disease
Open Access
- 22 March 1999
- journal article
- research article
- Published by American Medical Association (AMA) in Archives of internal medicine (1960)
- Vol. 159 (6) , 593-600
- https://doi.org/10.1001/archinte.159.6.593
Abstract
CARDIOVASCULAR disease (CVD), including coronary heart disease (CHD) and stroke, is the leading cause of death in most industrialized countries.1 Accordingly, much attention has been focused on recent clinical trials demonstrating that lipid modification with 3-hydroxy-3-methylglutaryl–coenzyme A reductase inhibitors (statins) can reduce the morbidity and mortality of secondary events among adults diagnosed as having CHD.2-4This publication has 15 references indexed in Scilit:
- Cost Effectiveness of Simvastatin Treatment to Lower Cholesterol Levels in Patients with Coronary Heart DiseaseNew England Journal of Medicine, 1997
- The Effect of Pravastatin on Coronary Events after Myocardial Infarction in Patients with Average Cholesterol LevelsNew England Journal of Medicine, 1996
- Cost-effectiveness of cholesterol lowering: Results from the Scandinavian Simvastatin Survival Study (4S)European Heart Journal, 1996
- Identifying adults at increased risk of coronary disease. How well do the current cholesterol guidelines work?Published by American Medical Association (AMA) ,1995
- Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S)The Lancet, 1994
- Guidelines for the management of patients with acute ischemic stroke. A statement for healthcare professionals from a special writing group of the Stroke Council, American Heart Association.Stroke, 1994
- Guidelines for the management of transient ischemic attacks. From the Ad Hoc Committee on Guidelines for the Management of Transient Ischemic Attacks of the Stroke Council of the American Heart Association.Stroke, 1994
- The Canadian American Ticlopidine Study (CATS) in thromboembolic stroke. Design, organization, and baseline results.Stroke, 1988
- Relative importance of after-effects, environment and socio-economic factors on the social integration of stroke victimsInternational Journal of Rehabilitation Research, 1988
- Lipoprotein-cholesterol distributions in selected North American populations: the lipid research clinics program prevalence study.Circulation, 1980